Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biofoundry Technologies
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Biofoundry Technologies produces GMP-consistent recombinant proteins, enzymes, and diagnostic kits for use in molecular biology research, diagnostics manufacturing (IVD), plant biotech R&D, food testing/GMO detection. Their products are animal origin-free and manufactured under ISO 9001/13485 workflows. They serve biopharma companies as well as diagnostic makers. No clinical results apply.
- Therapeutic areas
- Other
- Modalities
- Recombinant proteinEnzymeDiagnostic kitMolecular biology reagent
- Industry
- Non-Drug Biotech
02
Partnerships
Not specified in public sources. Focus appears to be direct sales to industry partners rather than formal partnerships.
Beyond the preview
Go deeper on Biofoundry Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biofoundry Technologies.